87
Participants
Start Date
December 31, 2004
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
salmeterol
50 micrograms (mcg) twice per day (BID) (Serevent 50 mcg diskus, GlaxoSmithKline (GSK), North Carolina)
beclomethasone HFA
240 mcg beclomethasone HFA (QVAR, Teva Pharmaceutical Industries)
Wake Forest University Health Sciences, Winston-Salem
Washington University, St Louis
National Jewish Medical & Research Center, Denver
University of California, San Diego, San Diego
University of California, San Francisco, San Francisco
Brigham & Women's Hospital, Boston
University of Wisconsin Madison, Madison
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Asthma Clinical Research Network
NETWORK
Milton S. Hershey Medical Center
OTHER